Dr Nick Samaras is CEO of MuriGen Therapeutics.
		Nick has over 20 years’ experience in the global life sciences industry and holds a PhD from the Walter & Eliza Hall Institute of Medical Research, University of Melbourne. He is also Chairman of Replikun Biotech Ltd, Teeleostin Ltd, Deputy Facility Board Chair of the AGRF Ltd, a Board Director of Human Genetic Signatures and a member of the NHMRC Research Committee.